Logo image of CNR

CORE NATURAL RESOURCES INC (CNR) Stock Fundamental Analysis

NYSE:CNR - New York Stock Exchange, Inc. - US2189371006 - Common Stock - Currency: USD

69.24  -1.96 (-2.75%)

After market: 70.26 +1.02 (+1.47%)

Fundamental Rating

5

CNR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 213 industry peers in the Oil, Gas & Consumable Fuels industry. CNR has an average financial health and profitability rating. CNR is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CNR was profitable.
CNR had a positive operating cash flow in the past year.
CNR had positive earnings in 4 of the past 5 years.
In the past 5 years CNR always reported a positive cash flow from operatings.
CNR Yearly Net Income VS EBIT VS OCF VS FCFCNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

CNR has a Return On Assets (1.84%) which is comparable to the rest of the industry.
The Return On Equity of CNR (2.96%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 3.20%, CNR is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for CNR is in line with the industry average of 25.88%.
The 3 year average ROIC (24.39%) for CNR is well above the current ROIC(3.20%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.84%
ROE 2.96%
ROIC 3.2%
ROA(3y)17.24%
ROA(5y)10.53%
ROE(3y)35.71%
ROE(5y)22.09%
ROIC(3y)24.39%
ROIC(5y)15.83%
CNR Yearly ROA, ROE, ROICCNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

With a Profit Margin value of 4.31%, CNR perfoms like the industry average, outperforming 42.25% of the companies in the same industry.
In the last couple of years the Profit Margin of CNR has grown nicely.
CNR's Operating Margin of 7.78% is on the low side compared to the rest of the industry. CNR is outperformed by 64.32% of its industry peers.
In the last couple of years the Operating Margin of CNR has grown nicely.
With a Gross Margin value of 23.23%, CNR is not doing good in the industry: 64.32% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CNR has declined.
Industry RankSector Rank
OM 7.78%
PM (TTM) 4.31%
GM 23.23%
OM growth 3Y12.32%
OM growth 5Y2.74%
PM growth 3Y70.14%
PM growth 5Y19.45%
GM growth 3Y-31.09%
GM growth 5Y-21.12%
CNR Yearly Profit, Operating, Gross MarginsCNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CNR is creating value.
The number of shares outstanding for CNR has been reduced compared to 1 year ago.
CNR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CNR has been reduced compared to a year ago.
CNR Yearly Shares OutstandingCNR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CNR Yearly Total Debt VS Total AssetsCNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CNR has an Altman-Z score of 1.85. This is not the best score and indicates that CNR is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 1.85, CNR is doing good in the industry, outperforming 64.32% of the companies in the same industry.
The Debt to FCF ratio of CNR is 4.13, which is a neutral value as it means it would take CNR, 4.13 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CNR (4.13) is better than 71.36% of its industry peers.
CNR has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
CNR has a Debt to Equity ratio of 0.08. This is in the better half of the industry: CNR outperforms 78.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 4.13
Altman-Z 1.85
ROIC/WACC0.3
WACC10.67%
CNR Yearly LT Debt VS Equity VS FCFCNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CNR has a Current Ratio of 1.89. This is a normal value and indicates that CNR is financially healthy and should not expect problems in meeting its short term obligations.
CNR has a Current ratio of 1.89. This is in the better half of the industry: CNR outperforms 74.65% of its industry peers.
CNR has a Quick Ratio of 1.34. This is a normal value and indicates that CNR is financially healthy and should not expect problems in meeting its short term obligations.
CNR's Quick ratio of 1.34 is fine compared to the rest of the industry. CNR outperforms 67.61% of its industry peers.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.34
CNR Yearly Current Assets VS Current LiabilitesCNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

7

3. Growth

3.1 Past

The earnings per share for CNR have decreased strongly by -63.31% in the last year.
The Earnings Per Share has been growing by 22.60% on average over the past years. This is a very strong growth
The Revenue has grown by 10.42% in the past year. This is quite good.
The Revenue has been growing by 9.16% on average over the past years. This is quite good.
EPS 1Y (TTM)-63.31%
EPS 3Y93.33%
EPS 5Y22.6%
EPS Q2Q%-105.01%
Revenue 1Y (TTM)10.42%
Revenue growth 3Y19.47%
Revenue growth 5Y9.16%
Sales Q2Q%83.33%

3.2 Future

CNR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.84% yearly.
CNR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.32% yearly.
EPS Next Y-7.41%
EPS Next 2Y15.48%
EPS Next 3Y10.32%
EPS Next 5Y9.84%
Revenue Next Year73.29%
Revenue Next 2Y38.58%
Revenue Next 3Y23.32%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CNR Yearly Revenue VS EstimatesCNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
CNR Yearly EPS VS EstimatesCNR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

CNR is valuated reasonably with a Price/Earnings ratio of 11.44.
CNR's Price/Earnings ratio is a bit cheaper when compared to the industry. CNR is cheaper than 61.97% of the companies in the same industry.
When comparing the Price/Earnings ratio of CNR to the average of the S&P500 Index (25.91), we can say CNR is valued rather cheaply.
A Price/Forward Earnings ratio of 5.40 indicates a rather cheap valuation of CNR.
Based on the Price/Forward Earnings ratio, CNR is valued cheaper than 89.67% of the companies in the same industry.
CNR is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.85, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.44
Fwd PE 5.4
CNR Price Earnings VS Forward Price EarningsCNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CNR.
The rest of the industry has a similar Price/Free Cash Flow ratio as CNR.
Industry RankSector Rank
P/FCF 41.66
EV/EBITDA 7.63
CNR Per share dataCNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.51
EPS Next 2Y15.48%
EPS Next 3Y10.32%

2

5. Dividend

5.1 Amount

CNR has a yearly dividend return of 0.96%, which is pretty low.
CNR's Dividend Yield is slightly below the industry average, which is at 6.72.
Compared to an average S&P500 Dividend Yield of 2.36, CNR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.96%

5.2 History

CNR has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
CNR Yearly Dividends per shareCNR Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

22.54% of the earnings are spent on dividend by CNR. This is a low number and sustainable payout ratio.
DP22.54%
EPS Next 2Y15.48%
EPS Next 3Y10.32%
CNR Yearly Income VS Free CF VS DividendCNR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M
CNR Dividend Payout.CNR Dividend Payout, showing the Payout Ratio.CNR Dividend Payout.PayoutRetained Earnings

CORE NATURAL RESOURCES INC

NYSE:CNR (5/22/2025, 8:04:00 PM)

After market: 70.26 +1.02 (+1.47%)

69.24

-1.96 (-2.75%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners57.44%
Inst Owner Change16031.4%
Ins Owners1.79%
Ins Owner Change20.33%
Market Cap3.70B
Analysts77.14
Price Target104.04 (50.26%)
Short Float %4.9%
Short Ratio2.63
Dividend
Industry RankSector Rank
Dividend Yield 0.96%
Yearly Dividend0.53
Dividend Growth(5Y)N/A
DP22.54%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date05-30 2025-05-30 (0.1)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-86.03%
Min EPS beat(2)-110.49%
Max EPS beat(2)-61.58%
EPS beat(4)2
Avg EPS beat(4)-21.33%
Min EPS beat(4)-110.49%
Max EPS beat(4)86%
EPS beat(8)5
Avg EPS beat(8)-9.02%
EPS beat(12)9
Avg EPS beat(12)9.18%
EPS beat(16)11
Avg EPS beat(16)-22.39%
Revenue beat(2)1
Avg Revenue beat(2)-10.94%
Min Revenue beat(2)-24.65%
Max Revenue beat(2)2.77%
Revenue beat(4)3
Avg Revenue beat(4)-0.94%
Min Revenue beat(4)-24.65%
Max Revenue beat(4)15.41%
Revenue beat(8)6
Avg Revenue beat(8)1.63%
Revenue beat(12)10
Avg Revenue beat(12)7.59%
Revenue beat(16)13
Avg Revenue beat(16)8.77%
PT rev (1m)-7.9%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)-35.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-33.72%
Revenue NQ rev (1m)-3.1%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.13%
Revenue NY rev (3m)21.11%
Valuation
Industry RankSector Rank
PE 11.44
Fwd PE 5.4
P/S 1.38
P/FCF 41.66
P/OCF 12.79
P/B 0.95
P/tB 0.95
EV/EBITDA 7.63
EPS(TTM)6.05
EY8.74%
EPS(NY)12.81
Fwd EY18.51%
FCF(TTM)1.66
FCFY2.4%
OCF(TTM)5.41
OCFY7.82%
SpS50.01
BVpS72.9
TBVpS72.9
PEG (NY)N/A
PEG (5Y)0.51
Profitability
Industry RankSector Rank
ROA 1.84%
ROE 2.96%
ROCE 3.75%
ROIC 3.2%
ROICexc 3.44%
ROICexgc 3.44%
OM 7.78%
PM (TTM) 4.31%
GM 23.23%
FCFM 3.32%
ROA(3y)17.24%
ROA(5y)10.53%
ROE(3y)35.71%
ROE(5y)22.09%
ROIC(3y)24.39%
ROIC(5y)15.83%
ROICexc(3y)28.23%
ROICexc(5y)18.22%
ROICexgc(3y)28.23%
ROICexgc(5y)N/A
ROCE(3y)28.54%
ROCE(5y)18.52%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y35.93%
ROICexc growth 5Y15.67%
OM growth 3Y12.32%
OM growth 5Y2.74%
PM growth 3Y70.14%
PM growth 5Y19.45%
GM growth 3Y-31.09%
GM growth 5Y-21.12%
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 4.13
Debt/EBITDA 0.66
Cap/Depr 69.58%
Cap/Sales 7.5%
Interest Coverage 250
Cash Conversion 58.32%
Profit Quality 77.07%
Current Ratio 1.89
Quick Ratio 1.34
Altman-Z 1.85
F-Score6
WACC10.67%
ROIC/WACC0.3
Cap/Depr(3y)74.91%
Cap/Depr(5y)64.93%
Cap/Sales(3y)7.37%
Cap/Sales(5y)8.18%
Profit Quality(3y)104.03%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-63.31%
EPS 3Y93.33%
EPS 5Y22.6%
EPS Q2Q%-105.01%
EPS Next Y-7.41%
EPS Next 2Y15.48%
EPS Next 3Y10.32%
EPS Next 5Y9.84%
Revenue 1Y (TTM)10.42%
Revenue growth 3Y19.47%
Revenue growth 5Y9.16%
Sales Q2Q%83.33%
Revenue Next Year73.29%
Revenue Next 2Y38.58%
Revenue Next 3Y23.32%
Revenue Next 5YN/A
EBIT growth 1Y-66.77%
EBIT growth 3Y34.19%
EBIT growth 5Y12.15%
EBIT Next Year112.97%
EBIT Next 3Y38.11%
EBIT Next 5Y24.53%
FCF growth 1Y-84.76%
FCF growth 3Y19.97%
FCF growth 5Y31.85%
OCF growth 1Y-61.5%
OCF growth 3Y15.95%
OCF growth 5Y14.26%